These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32826388)

  • 21. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19-Related Stroke.
    Hess DC; Eldahshan W; Rutkowski E
    Transl Stroke Res; 2020 Jun; 11(3):322-325. PubMed ID: 32378030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
    Theoharides TC
    Biofactors; 2020 May; 46(3):306-308. PubMed ID: 32339387
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytokine storm and the prospects for immunotherapy with COVID-19.
    Calabrese LH
    Cleve Clin J Med; 2020 Jun; 87(7):389-393. PubMed ID: 32393592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 27. The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets.
    Casucci G; Acanfora D; Incalzi RA
    Drugs Aging; 2020 Nov; 37(11):779-785. PubMed ID: 33084001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine Storms: Understanding COVID-19.
    Mangalmurti N; Hunter CA
    Immunity; 2020 Jul; 53(1):19-25. PubMed ID: 32610079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem Cell Transplantation Therapy: A Potential Method for Treating Cytokine Storm Syndromes Induced by COVID-19.
    Wang HC; Wang X; Long X
    Cell Transplant; 2020; 29():963689720965980. PubMed ID: 33040594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Overview on Hypercoagulability in COVID-19.
    Singhania N; Bansal S; Nimmatoori DP; Ejaz AA; McCullough PA; Singhania G
    Am J Cardiovasc Drugs; 2020 Oct; 20(5):393-403. PubMed ID: 32748336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Science Underlying COVID-19: Implications for the Cardiovascular System.
    Liu PP; Blet A; Smyth D; Li H
    Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is susceptibility to severe COVID-19 disease an inborn error of metabolism?
    Clayton PT
    J Inherit Metab Dis; 2020 Sep; 43(5):906-907. PubMed ID: 32608016
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19 and Cardiovascular Disease.
    Clerkin KJ; Fried JA; Raikhelkar J; Sayer G; Griffin JM; Masoumi A; Jain SS; Burkhoff D; Kumaraiah D; Rabbani L; Schwartz A; Uriel N
    Circulation; 2020 May; 141(20):1648-1655. PubMed ID: 32200663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
    Gupta SP
    Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preterm birth: Potential risk factor for greater COVID-19 severity?
    Debevec T; Burtscher J; Millet GP
    Respir Physiol Neurobiol; 2020 Sep; 280():103484. PubMed ID: 32599161
    [No Abstract]   [Full Text] [Related]  

  • 37. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
    Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
    Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of IgA in COVID-19.
    Chao YX; Rötzschke O; Tan EK
    Brain Behav Immun; 2020 Jul; 87():182-183. PubMed ID: 32454136
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.
    Turgeon RD; Zieroth S; Bewick D; Chow CM; Clarke B; Cowan S; Fordyce CB; Fournier A; Gin K; Gupta A; Hardiman S; Jackson S; Lau B; Leong-Poi H; Mansour S; Marelli A; Quraishi AR; Roifman I; Ruel M; Sapp J; Singh G; Small G; Virani S; Wood DA; Krahn A
    Can J Cardiol; 2020 Aug; 36(8):1180-1182. PubMed ID: 32502522
    [No Abstract]   [Full Text] [Related]  

  • 40. The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study.
    Tsantes AE; Frantzeskaki F; Tsantes AG; Rapti E; Rizos M; Kokoris SI; Paramythiotou E; Katsadiotis G; Karali V; Flevari A; Chrysanthopoulou E; Maratou E; Kyriakou E; Gialeraki A; Bonovas S; Dimopoulos G; Tsangaris I; Armaganidis A
    Medicine (Baltimore); 2020 Nov; 99(47):e23365. PubMed ID: 33217881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.